17-36581503-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_024835.5(GGNBP2):c.1180C>A(p.Gln394Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000925 in 1,610,326 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_024835.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GGNBP2 | ENST00000613102.5 | c.1180C>A | p.Gln394Lys | missense_variant | Exon 9 of 14 | 1 | NM_024835.5 | ENSP00000478220.1 | ||
GGNBP2 | ENST00000617860.4 | n.2523C>A | non_coding_transcript_exon_variant | Exon 8 of 8 | 2 | |||||
GGNBP2 | ENST00000618837.4 | n.1452C>A | non_coding_transcript_exon_variant | Exon 9 of 10 | 2 | |||||
GGNBP2 | ENST00000619573.1 | n.1865C>A | non_coding_transcript_exon_variant | Exon 3 of 6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152142Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000685 AC: 17AN: 248220Hom.: 0 AF XY: 0.0000670 AC XY: 9AN XY: 134262
GnomAD4 exome AF: 0.0000905 AC: 132AN: 1458184Hom.: 0 Cov.: 30 AF XY: 0.0000799 AC XY: 58AN XY: 725486
GnomAD4 genome AF: 0.000112 AC: 17AN: 152142Hom.: 1 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74320
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1180C>A (p.Q394K) alteration is located in exon 9 (coding exon 8) of the GGNBP2 gene. This alteration results from a C to A substitution at nucleotide position 1180, causing the glutamine (Q) at amino acid position 394 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at